Marketwatch Global PE funds eye stake in GVK Bio, co valued at $800 mn Admin November 5, 2020 In this proposed transaction, GVK BIO- promoted by the GVK Group and DS Brar, the former CEO and managing director of Ranbaxy Laboratories, will be valued at $750-800 million (Rs 5500-6000 crore), said multiple people aware of the development. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
